BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100.
| Date | Est. | Actual | |
|---|---|---|---|
| May 13, 2026 | -$6.00 | -$0.24 | Beat |
| Mar 26, 2026 | -$7.40 | -$7.40 | Beat |
| Nov 12, 2025 | -$7.20 | -$6.60 | Beat |
| Aug 12, 2025 | -$7.40 | -$0.30 | Beat |
| May 14, 2025 | -$6.40 | -$12.80 | Miss |
| Apr 4, 2025 | -$5.40 | -$7.50 | Miss |